Insider Transactions in Q1 2021 at Cara Therapeutics, Inc. (CARA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2021
|
Derek T Chalmers President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
52,000
+4.93%
|
-
|
|
Mar 30
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+25.56%
|
-
|
|
Mar 30
2021
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+10.57%
|
-
|
|
Mar 30
2021
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+19.2%
|
-
|
|
Mar 22
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-8.93%
|
$57,000
$19.65 P/Share
|
|
Mar 05
2021
|
Derek T Chalmers President & CEO |
SELL
Open market or private sale
|
Direct |
3,103
-0.33%
|
$52,751
$17.98 P/Share
|
|
Mar 05
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,093
-8.43%
|
$52,581
$17.98 P/Share
|
|
Mar 05
2021
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
3,090
-5.68%
|
$52,530
$17.98 P/Share
|
|
Mar 05
2021
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
3,358
-2.74%
|
$57,086
$17.98 P/Share
|
|
Mar 04
2021
|
Derek T Chalmers President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+1.04%
|
-
|
|
Mar 04
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+21.41%
|
-
|
|
Mar 04
2021
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+15.52%
|
-
|
|
Mar 04
2021
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+7.54%
|
-
|
|
Feb 25
2021
|
Derek T Chalmers President & CEO |
SELL
Open market or private sale
|
Direct |
11,729
-1.23%
|
$222,851
$19.33 P/Share
|
|
Feb 25
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,372
-11.21%
|
$64,068
$19.33 P/Share
|
|
Feb 25
2021
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
5,003
-4.25%
|
$95,057
$19.33 P/Share
|
|
Feb 25
2021
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
4,004
-8.27%
|
$76,076
$19.33 P/Share
|
|
Feb 23
2021
|
Derek T Chalmers President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+1.92%
|
-
|
|
Feb 23
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+11.74%
|
-
|
|
Feb 23
2021
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+6.37%
|
-
|
|
Feb 23
2021
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+11.02%
|
-
|
|
Feb 22
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-7.12%
|
$38,000
$19.73 P/Share
|
|
Jan 21
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-6.65%
|
$40,000
$20.12 P/Share
|